Contract for SteriPET (F-18-FDG), 18F-2’-Fluoro-2-Deoxy Glucose Products for St Olavs Hospital Health Trust

Information

15 - Voluntary ex ante transparency notice
Award of a contract without prior publication of a contract notice in the Official Journal of the European Union
12/1/2018 9:31 AM (GMT+01:00)

Buyer

Sykehusinnkjøp HF Sykehusinnkjøp HF
Anita Sand Anita Sand
Hermetikken Tollbugata 7
9800 Vadsø
Norway
916 879 067

Assignment text

It has been decided that St. Olavs Hospital Health Trust shall enter into a Framework Agreement for SteriPET (F-18-FDG), 18F-2’-fluoro-2-deoxy glucose products. SteriPET is a radioactive preparation with half the time, 109 minutes. The preparation's shelf life is 10 hours from the completed synthesis. SteriPET shall be used for diagnostics by utilising PET (positron emission tomography). St Olavs Hospital Health Trust needs 3-5 weekly deliveries of FDG. Only GE Healthcare AS has the marketing permission in Norway for the above mentioned products. GE Healthcare AS also has the special wholesaler permission applying to Radiopharmaceuticals with direct distribution of 18F-FDG. This contract can consequently only be carried out by a particular supplier. Cf. the Public Procurement Regulations §13-4 b) point 3.

Mercell Holding AS

Part of the Mercell Group, one of Europe’s leading providers of e tender systems and information between buyers and suppliers in the professional market.

Contact us

Write to us

+47 21 01 88 00